longboardpharma.com (LBPH) - Forvard P/S multiplikatori

Longboard (LBPH) kompaniyasining rasmiy ramzlari

Longboard Pharmaceuticals laboratoriya xavfsizligi va raqamli hujjatlar orqali ekologik qoidalarga rioya qiladi. Tashkilotning qiymatida qat'iy belgilangan prognozli P/S ko'rsatkichi bozor qiymatini fundamental ko'rsatkichlar bilan bog'laydi. Longboard Pharmaceuticals himoyalangan patentlar va likvid kapitalga ega. Biznesning moliyaviy muvaffaqiyati rivojlanishdan ortda qolish va epilepsiya uchun innovatsion davolash vositalarining tijoratga chiqarilishiga bog'liq.

LBPH (Longboard Pharmaceuticals, Inc.) Sotuvga nisbatan forvard narx tarixi 04.07.2022dan 14.11.2026gacha

Longboard (LBPH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
Narx grafigi Longboard Pharmaceuticals, Inc.|LBPH - Adolatli qiymat konsensusi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi Longboard|LBPH - Biznes qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya uchun buxgalteriya qiymati Longboard Pharmaceuticals|LBPH - Kompaniyaning buxgalteriya qiymati|Bozor qiymatining balans qiymatiga nisbati longboardpharma.com|LBPH - Kompaniya aktivlarining umumiy qiymati
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Longboard Pharmaceuticals|LBPH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Longboard Pharmaceuticals|LBPH - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Longboard|LBPH - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Longboard Pharmaceuticals|Tezkor likvidlik koeffitsiyenti longboardpharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
LBPH - Sof foyda|Prognoz qilingan kelajakdagi foyda Longboard Pharmaceuticals|LBPH - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Longboard Pharma|LBPH - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Longboard|LBPH - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Longboard Pharmaceuticals|LBPH - So'nggi to'rtta chorak uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi longboardpharma.com|LBPH - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Longboard Pharmaceuticals
- kompaniyaning sotuvlari va tushumi statistikasi:
LBPH - Kompaniya savdosi|Prognoz qilingan sotish hajmi Longboard Pharmaceuticals, Inc.|LBPH - P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Longboard
Kompaniyaning fundamental tahlili:LBPH (Longboard Pharmaceuticals, Inc.)
Longboard tovar namunasi

Longboard Pharmaceuticals (LBPH) uchun, uning nevrologiya bo'yicha faoliyati AQSh bozori tufayli geosiyosiy xavflardan himoyalangan, ushbu ko'rsatkich kelajakdagi savdolarga nisbatan bozor optimizmini o'lchovchi vosita bo'lib xizmat qiladi. Forward price-to-sales koeffitsiyenti grafigini tahlil qilish orqali investor joriy bozor kapitalizatsiyasi va prognoz qilingan daromadlar o'rtasidagi bog'liqlikni baholaydi, bunda yuqori qiymatlar aktivning haddan tashqari sotib olinganligini, past qiymatlar esa o'sish potentsialining yetarlicha baholanmaganligini anglatadi.

Muhim raqobatchilar

Narxning prognoz qilingan daromadga nisbati Biogen BIIB|Sotuvga nisbatan forvard narx NBIX|Regencell - Forvard P/S multiplikatori|AXSM (Axsome Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ACAD (ACADIA Pharmaceuticals) - Forvard narx/daromad multiplikatori|xenon-pharma.com - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Therapeutics, Inc.|Supernus Pharmaceuticals, Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori CPRX|DNLI (Denali Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori HRMY (Harmony Biosciences)|Forvard P/S multiplikatori biohavenpharma.com BHVN|AMLX - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Anavex Life Sciences Corp|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Prothena Corporation|Forvard P/S multiplikatori ALEC|Forvard narx/daromad multiplikatori Annexon Biosciences ANNX|Forvard P/S multiplikatori OMER (Omeros)|Neurogene Therapeutics (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ACIU: Forvard narx/daromad multiplikatori|VYGR - Forvard P/S multiplikatori|NMRA (Neumora Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|SCLX: Narxning kutilayotgan daromadga nisbati|TVGN (Tevogen Bio Holdings, Inc.) - Forvard P/S multiplikatori|Alpha Cognition Corp (ACOG) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori CGTX|Forvard narx/daromad multiplikatori inhibikase.com IKT|Forvard P/S multiplikatori SAVA (Cassava Sciences)|Forvard P/S multiplikatori Assertio Holdings ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|VTGN: Narxning prognoz qilingan daromadga nisbati|ovidrx.com (OVID) - Narxning prognoz qilingan daromadga nisbati|ABOS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CervoMed|Narxning prognoz qilingan daromadga nisbati ATHE|Forvard P/S multiplikatori CLNN|Narxning prognoz qilingan daromadga nisbati PEPG (pepgen.com)|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|RLMD (relmada.com) - Kelajakdagi narxning daromadga nisbati|Annovis Bio - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx GRCE (Grace Therapeutics, Inc.)|Firefly Neuroscience Inc (AIFF) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati KLTO|NRSN (NeuroSense Therapeutics Ltd) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati revivapharma.com RVPH|Forvard narx/daromad multiplikatori MTVA (MetaVia Inc)|Forvard P/S multiplikatori NeurAxis Inc. (NRXS)|Narxning prognoz qilingan daromadga nisbati Helius Medical Technologies HSDT|Sotuvga nisbatan forvard narx PASG|NEUP - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati minervaneurosciences.com|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|ADXN (Addex Therapeutics Ltd.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Alzamend Neuro Inc.|Bozor kapitallashuvining kelajakdagi daromadga nisbati Cyclerion CYCN|Narxning prognoz qilingan daromadga nisbati Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori CRGT (Cortigent)|Prognoz narxning daromadga nisbati Avenue Therapeutics Inc.|Brainstorm Cell Therapeutics, Inc. - Forvard P/S multiplikatori|CARA: Narxning prognoz qilingan daromadga nisbati|Chromocell Therapeutics (CHRO) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Eliem Therapeutics Inc. (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Marinus Pharmaceuticals Inc|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NRBO (NeuroBo Pharma) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|SNPX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|TRVN: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx VIGL (Vigil Neuroscience)|Anew Medical (WENA) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CERE (Cerevel Corp)